Table 1.
Antibiotic resistance phenotype analyses of PDD SSPD1601.
| Drugs | Concentration (μg/disc) | Diameter of inhibition (mm) | Sensitivity |
|---|---|---|---|
| Neomycin | 30 | 21 | S |
| Ceftazidime | 30 | 10 | R |
| Pipemidic | 30 | 19 | R |
| Tetracycline | 30 | 20 | S |
| Bacitracin | 0.04 U | 0 | R |
| Ofloxacin | 5 | 22 | S |
| Streptomycin | 10 | 12 | R |
| Norfloxacin | 10 | 22 | S |
| Cefalexin | 9 | 13 | R |
| Cefradine | 30 | 17 | I |
| Cefoperazone sodium | 75 | 11 | R |
| Cefazolin | 30 | 16 | I |
| Fleroxacin | 5 | 22 | S |
| Acetylspiramycin | 30 | 0 | R |
| Clarithromycin | 15 | 11 | R |
| Amikacin | 30 | 14 | R |
| Gentamycin | 10 | 13 | R |
| Azithromycin | 15 | 14 | I |
| Kanamycin | 30 | 10 | R |
| Oxacillin | 1 | 0 | R |
| Ampicillin | 10 | 0 | R |
| Polymyxin B | 300 U | 10 | I |
| Florfenicol | 30 | 22 | S |
| Trimethoprim-sulfamethoxazole | 25 | 17 | R |
| Nalidixic acid | 30 | 24 | S |
Note: S, sensitivity; I, moderate sensitivity; R, resistance.